Literature DB >> 21962285

Comparison of urine protein profiles in cats without urinary tract disease and cats with idiopathic cystitis, bacterial urinary tract infection, or urolithiasis.

Stephanie I K Lemberger1, Cornelia A Deeg, Stefanie M Hauck, Barbara Amann, Sieglinde Hirmer, Katrin Hartmann, Roswitha Dorsch.   

Abstract

OBJECTIVE: To characterize and compare the urine protein content in cats without urinary tract disease and cats with idiopathic cystitis (IdC), bacterial urinary tract infection (UTI), or urolithiasis. ANIMALS: Control cats (n = 18) and cats with IdC (18), UTI (12), and urolithiasis (12) from which urine samples were obtained and 2 cats with obstructive IdC and 4 additional control cats from which postmortem urinary bladder biopsy specimens were obtained. PROCEDURES: Protein contents in urine samples obtained via cystocentesis or catheterization were measured via the Bradford method. Urine proteins were separated by means of 1-dimensional gel electrophoresis. Evaluation of fibronectin content was performed via western blotting and immunohistochemical analysis. Urinary bladder biopsy specimens were examined histologically and analyzed immunohistochemically for fibronectin.
RESULTS: Urine fibronectin content was significantly greater in cats with IdC, compared with control cat findings. Urine fibronectin contents did not differ significantly among controls and cats with UTI or urolithiasis. Histologic examination of bladder biopsy specimens obtained from 2 cats with obstructive IdC revealed destruction of the urothelial lining of the urinary bladder and severe fibrosis; immunohistochemical analysis revealed few fluorescence signals for fibronectin, unlike findings in control bladder biopsy specimens. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that urine fibronectin content in cats with IdC was greater than that in controls, cats with UTI, or cats with urolithiasis. In cats with IdC, increased permeability of damaged urothelium may result in detachment and leakage of fibronectin into urine. Urine fibronectin might serve as a biomarker for diagnosis of IdC in cats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962285     DOI: 10.2460/ajvr.72.10.1407

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

Review 1.  Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Management of Feline Idiopathic Cystitis: An Update Review.

Authors:  Chengxi He; Kai Fan; Zhihui Hao; Na Tang; Gebin Li; Shuaiyu Wang
Journal:  Front Vet Sci       Date:  2022-06-21

2.  Evaluation of lower urinary tract disease in the Yogyakarta cat population, Indonesia.

Authors:  Alfarisa Nururrozi; Yanuartono Yanuartono; Prisyarlinie Sivananthan; Soedarmanto Indarjulianto
Journal:  Vet World       Date:  2020-06-25

3.  Novel potential interacting partners of fibronectin in spontaneous animal model of interstitial cystitis.

Authors:  Gudrun Treutlein; Roswitha Dorsch; Kerstin N Euler; Stefanie M Hauck; Barbara Amann; Katrin Hartmann; Cornelia A Deeg
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

4.  Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis.

Authors:  M Parys; V Yuzbasiyan-Gurkan; J M Kruger
Journal:  J Vet Intern Med       Date:  2018-01-22       Impact factor: 3.333

5.  Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis.

Authors:  F Aura Kullmann; Bronagh M McDonnell; Amanda S Wolf-Johnston; Andrew M Lynn; Daniel Giglio; Samuel E Getchell; Wily G Ruiz; Irina V Zabbarova; Youko Ikeda; Anthony J Kanai; James R Roppolo; Sheldon I Bastacky; Gerard Apodaca; C A Tony Buffington; Lori A Birder
Journal:  Front Syst Neurosci       Date:  2018-04-13

6.  A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis.

Authors:  Ran Nivy; Gilad Segev; Dar Rimer; Yaron Bruchim; Itamar Aroch; Michal Mazaki-Tovi
Journal:  J Vet Intern Med       Date:  2019-08-10       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.